|
YPEL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.048200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.507000E-01 |
| Normal-vs-Stage2 |
2.651200E-01 |
| Normal-vs-Stage3 |
1.638580E-01 |
| Normal-vs-Stage4 |
2.988800E-01 |
| Stage1-vs-Stage2 |
1.931810E-01 |
| Stage1-vs-Stage3 |
6.516300E-02 |
| Stage1-vs-Stage4 |
1.712590E-01 |
| Stage2-vs-Stage3 |
9.661000E-01 |
| Stage2-vs-Stage4 |
8.629400E-01 |
| Stage3-vs-Stage4 |
8.066200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.694400E-01 |
| Normal-vs-AfricanAmerican |
9.255000E-01 |
| Normal-vs-Asian |
5.929000E-01 |
| Caucasian-vs-AfricanAmerican |
6.031200E-01 |
| Caucasian-vs-Asian |
2.141000E-01 |
| AfricanAmerican-vs-Asian |
7.365600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.718000E-01 |
| Normal-vs-Female |
4.055200E-01 |
| Male-vs-Female |
3.616600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.031000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.606800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.716700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.846600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.326200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.006800E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.710400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.639700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.757400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.842600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.013800E-02 |
| Classical-VS-Follicular |
8.98609999744338E-08 |
| Classical-VS-Other |
9.413600E-01 |
| Classical-VS-Normal |
5.567400E-01 |
| Tall-VS-Follicular |
4.488100E-02 |
| Tall-VS-Other |
4.835400E-01 |
| Tall-VS-Normal |
2.702800E-01 |
| Follicular-VS-Other |
7.361800E-02 |
| Follicular-VS-Normal |
2.319800E-03 |
| Other-VS-Normal |
7.816800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.627570E-01 |
| Normal-vs-N1 |
4.616000E-01 |
| N0-vs-N1 |
6.277400E-01 |
|
|
